Clinical Trial Update: Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating safety and efficacy of a fourth-generation CAR-T therapy for hematologic malignancies, including multiple myeloma and B-cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Multiple Myeloma

Drugs mentioned

• Fourth-generation CAR-T therapy

Snippet

Sponsor: The Third Affiliated Hospital of Southern Medical University | Conditions: Multiple Myeloma, B-cell Lymphoma | Phase 1 | Status: RECRUITING